Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964834 · ClinicalTrials.gov registry record · Phase 1
Ph1 Study of Valortim and Doxycycline in Humans
A Phase 1 study, sponsored by PharmAthene.
- Terminated
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00964834 is a Phase 1 study that was terminated before completion, run by PharmAthene. The registered enrollment target is 24 participants.
The verdict
NCT00964834, a Phase 1 study, was terminated before completion, sponsored by PharmAthene.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of short-term dosing of IV doxycycline when administered concomitantly with IV Valortim in normal healthy human subjects.
Interventions
- DRUG Doxycycline and Valortim
- DRUG Placebo Antibiotic and Valortim
- DRUG Placebo Antibiotic and Placebo Valortim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00964834
The ClinicalTrials.gov registry entry for NCT00964834 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PharmAthene, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Doxycycline and Valortim is the first listed.
NCT00964834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00964834 about?
NCT00964834 is a clinical study titled "Ph1 Study of Valortim and Doxycycline in Humans". The purpose of this study is to evaluate the safety and tolerability of short-term dosing of IV doxycycline when administered concomitantly with IV Valortim in normal healthy human subjects.
What is the current status of trial NCT00964834?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2009-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00964834?
The interventions under investigation include: Doxycycline and Valortim (DRUG), Placebo Antibiotic and Valortim (DRUG), Placebo Antibiotic and Placebo Valortim (DRUG).
Who is sponsoring clinical trial NCT00964834?
This trial is sponsored by PharmAthene, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.